MS4A1 and rhabdomyosarcoma: Numerous studies have registered a low frequency of CD20+ cells infiltrating STSs [19,20,21], and in one study on rhabdomyosarcoma, CD20+ tumor-infiltrating cells were identified only at the periphery of the tumor [22].